Riskpilot← Back to searchSign inGet full accessMayomed AB
ABIn liquidationOrg 5590317334Medical specialists activities · NACE 8622Est. 20150 employees
Revenue 2024
—
EBITDA margin
—
-100% vs 2023
Equity ratio
31.2%
Financial strength
Net profit 2024
SEK 148K
+256% vs 2023
| Revenue | — | — |
| EBITDA | SEK -81K | -100% |
| Net profit | SEK 148K | +256% |
| Total assets | SEK 1,1M | +20% |
| Equity | SEK 333K | +80% |
| Employees | 0 | — |
Legal name
Mayomed AB
Org number
5590317334
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 oktober 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva medicinsk verksamhet, främst inom läkarområdet, äga och förvalta värdepapper och fast egendom och därmed förenlig verksamhet.
Address
Email
larsake@wikensjo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | −3 | −5 |
| EBITDA | −50 | −35 | −52 | −41 | −81 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −50 | −35 | −52 | −41 | −81 |
| Net financials | — | — | — | — | 214 |
| Profit before tax | 2 | 0 | 4 | 51 | 189 |
| Tax | −0 | −0 | −0 | −10 | −41 |
| Net profit | 2 | 0 | 4 | 42 | 148 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 017 | 987 | 957 | 885 | 1 066 |
| Equity | 459 | 300 | 143 | 185 | 333 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 319 | 484 | 666 | 644 | 733 |
| Total debt | 319 | 484 | 666 | 644 | 733 |
EBITDA margin
-8149200.0%
This company
15.8%
Market median
-51577315% vs market
20202024
Equity ratio
31.2%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
44.5%
This company
18.4%
Market median
+142% vs market
20202024
Net profit margin
14804700.0%
This company
8.1%
Market median
+182773974% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LÅ Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mayomed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Åke Erland Wikensjö | Liquidator | 0 companies |
| Bo Stellan Björck | Board of Directors | 0 companies |
| Maria Gabriella Björk | Deputy Board Member | 0 companies |